If you have been reading about Salvage pathway and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-02-16. Where a claim depends on a specific study, the study is described rather than over-claimed.
Terminology around NMN can be confusing because several related compounds share the vitamin B3 family. Nicotinamide riboside is a nucleoside, whereas NMN is a nucleotide with a phosphate group, and NAD+ is a dinucleotide coenzyme rather than a simple precursor. Niacin and nicotinamide are also NAD+ precursors but follow different metabolic entry points. In commercial and scientific writing, NMN usually refers to beta-nicotinamide mononucleotide unless another form is specified. Consistent nomenclature helps distinguish chemical identity from proposed biological effects.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a pyridine nucleotide that consists of a nicotinamide ring, a ribose sugar, and a phosphate group. It is an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+, synthesis. In mammalian cells, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. Nicotinamide mononucleotide adenylyltransferases then convert NMN into NAD+. The core structure and enzymatic route are well established in biochemical literature.
Identity and purity of NMN are commonly assessed by liquid chromatography with ultraviolet detection or mass spectrometry. High-performance liquid chromatography can separate related impurities such as nicotinamide, nicotinamide riboside, and NAD+ depending on the method. Mass spectrometry provides molecular mass confirmation, while nuclear magnetic resonance spectroscopy helps establish structure and anomeric form. Quantitative assays often use calibration curves and, in biological samples, stable isotope-labeled internal standards. Method validation addresses specificity, linearity, accuracy, precision, and limits of detection.
Quality control for NMN materials typically includes appearance, assay, impurity profile, residual solvents, heavy metals, and microbial limits. A certificate of analysis summarizes specified tests, but the underlying methods and laboratory accreditation matter. Regulatory treatment varies by country; NMN is sold as a dietary supplement in some markets, while other jurisdictions restrict its use in foods or classify it differently. Independent verification can reduce risks of mislabeling or substitution. Questions remain about how product purity, storage history, and formulation affect delivered dose in humans.
| Property | Value | Notes |
|---|---|---|
| Systematic class | Pyridine nucleotide | Contains nicotinamide, ribose, and phosphate |
| Common form | beta-NMN | Anomeric configuration relevant to enzyme recognition |
| Molecular formula | C11H15N2O8P | As the free acid |
| Molar mass | 334.22 g/mol | Calculated for the free acid |
| CAS Registry Number | 1094-61-7 | Commonly associated with beta-D-NMN |
Research interest in NMN increased after animal studies reported that oral or injected NMN can raise NAD+ levels in some tissues. How NMN is absorbed and distributed in humans is not fully established. Some evidence suggests extracellular NMN may be dephosphorylated to nicotinamide riboside before cellular uptake, while other studies propose specific transport routes. Direct human data on these mechanisms remain limited. Regulatory status also varies: in some countries NMN is treated as a dietary supplement, while elsewhere it is restricted or requires approval, and these differences affect labeling, sale, and research.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms. Its structure consists of a nicotinamide group linked to a ribose sugar that carries a phosphate group. NMN is an intermediate in the biosynthesis of nicotinamide adenine dinucleotide, or NAD+, a coenzyme involved in many metabolic reactions. The abbreviation usually refers to the beta anomer, though related forms can exist. In scientific literature, NMN is distinct from nicotinamide riboside, another NAD+ precursor.
Analytical identification of NMN commonly uses high-performance liquid chromatography with ultraviolet detection, liquid chromatography-mass spectrometry, and nuclear magnetic resonance spectroscopy; HPLC can estimate purity by peak area, while mass spectrometry confirms molecular mass and fragmentation. NMR provides structural confirmation. Because NMN is charged, ion-pairing reagents or hydrophilic interaction liquid chromatography columns can improve retention and peak shape. In biological samples, LC-MS/MS with stable isotope internal standards is often used to quantify NMN and related NAD+ metabolites. Method validation is important because matrix effects and rapid enzymatic interconversion can complicate measurements.
Quality control for NMN typically checks identity, assay purity, residual solvents, heavy metals, and microbial limits, depending on the intended use and market. A certificate of analysis may report appearance, solubility, water content, and storage recommendations. Independent verification can compare chromatographic retention time and mass spectrum against a certified reference standard. Regulatory expectations differ between research chemicals, dietary ingredients, and pharmaceutical products. Impurity profiles and stability data are often requested for product approval, and open questions remain about how best to standardize NMN measurements across laboratories.
Nicotinamide mononucleotide, abbreviated NMN, is a nucleotide composed of nicotinamide, ribose, and phosphate. Its structure links nicotinamide to D-ribose 5-phosphate through a glycosidic bond, placing it in the pyridine nucleotide family. The compound exists in alpha and beta anomeric forms, and the beta form is the one used in NAD+ biosynthesis. NMN is not a protein or a hormone; it is a small water-soluble molecule that occurs in living cells as a metabolic intermediate.
Natural sources of NMN include mammals, plants, and microorganisms, where it functions as an intermediate in NAD+ salvage and biosynthesis pathways. In mammals, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferase. Some foods contain measurable NMN, but reported amounts vary widely by species, tissue, and analytical method. The extent to which dietary NMN contributes to cellular NAD+ pools remains an open research question.
Common laboratory methods for NMN include high-performance liquid chromatography with ultraviolet detection, liquid chromatography coupled to mass spectrometry, and nuclear magnetic resonance spectroscopy. Because the nicotinamide ring absorbs ultraviolet light, HPLC-UV at wavelengths near 260 nm can be used for purity assessment. LC-MS and LC-MS/MS provide greater sensitivity and are often applied to biological samples. Identification typically relies on matching retention time, mass-to-charge ratio, and fragmentation pattern to a reference standard.
NMN is generally handled as a hygroscopic and light-sensitive solid in laboratory settings. Recommended storage is typically at -20°C or below, often under desiccation and protected from light. Aqueous solutions are less stable than the solid and may degrade through hydrolysis or other pathways, so fresh preparation is common for analytical work. Repeated freeze-thaw cycles can reduce sample integrity. Stability depends on pH, temperature, buffer composition, and the presence of metal ions, so specific shelf-life values should be determined experimentally rather than assumed.
Quality control for NMN samples often includes purity determination by HPLC, identity confirmation by mass spectrometry or NMR, and water content measurement by Karl Fischer titration. Certificates of analysis may report residual solvents, heavy metals, and microbial limits depending on the intended use. Purity values are method-dependent, so a stated percentage should be interpreted alongside the analytical procedure and detection wavelength. Reference standards help ensure that retention times and spectral data are comparable across laboratories. Researchers increasingly request independent verification because supply chains for specialty chemicals can vary in documentation.
=== Oxides: ferrites === Ferrite nanoparticles or iron oxide nanoparticles (iron oxides in crystal structure of maghemite or magnetite) are the most explored magnetic nanoparticles up to date. Once the ferrite particles become smaller than 128 nm they become superparamagnetic which prevents self agglomeration since they exhibit their magnetic behavior only when an external magnetic field is applied. The magnetic moment of ferrite nanoparticles can be greatly increased by controlled clustering of a number of individual superparamagnetic nanoparticles into superparamagnetic nanoparticle clusters, namely magnetic nanobeads. With the external magnetic field switched off, the remanence falls back to zero. Just like non-magnetic oxide nanoparticles, the surface of ferrite nanoparticles is often modified by surfactants, silica, silicones or phosphoric acid derivatives to increase their stability in solution.
Gabapentinoids, also known as α2δ ligands, are a class of drugs that are chemically derivatives of the inhibitory neurotransmitter gamma-Aminobutyric acid (GABA) (i.e., GABA analogues) which bind selectively to the α2δ protein that was first described as an auxiliary subunit of voltage-gated calcium channels (VGCCs). Clinically used gabapentinoids include gabapentin, pregabalin, baclofen and mirogabalin, as well as a gabapentin prodrug, gabapentin enacarbil. Further analogues like imagabalin and atagabalin have been tested in clinical trials but their development has been halted. Other gabapentinoids which are used in scientific research but have not been approved for medical use include 4-methylpregabalin and PD-217,014.
== Mechanism of action == Pembrolizumab is a therapeutic antibody that binds to and blocks PD-1 located on lymphocytes. This receptor is generally responsible for preventing the immune system from attacking the body's own tissues; it is a so-called immune checkpoint. Normally, the PD-1 receptor on activated T-cells binds to the PD-L1 or PD-L2 ligands present on normal cells in the body, deactivating any potential cell-mediated immune response against these cells. Many cancers make proteins such as PD-L1 that also bind to the PD-1 receptor, thus shutting down the ability of the body to kill the cancer. Pembrolizumab works by inhibiting lymphocytes' PD-1 receptors, blocking the ligands that would deactivate it and prevent an immune response. This allows the immune system to target and destroy cancer cells, but also blocks a key mechanism preventing the immune system from attacking the body itself. This checkpoint inhibitor function of pembrolizumab thus has immune-dysfunction side effects as a result. Tumors often have mutations that cause impaired DNA mismatch repair. This in turn often results in microsatellite instability allowing the tumor to generate numerous mutant proteins that could serve as tumor antigens, triggering an immune response against the tumor. By preventing the self-checkpoint system from blocking the T-cells, pembrolizumab appears to facilitate clearance of any such tumor by the immune system.
For instance, knockdown of ACP reduces ceramide levels, whereas loss of the terminal mtFAS enzyme MECR results in ceramide accumulation. Importantly, mtFAS function extends to the regulation of immune cell metabolism. CRISPR/Cas9 screens have identified mtFAS genes—especially Mecr, Mcat, and Oxsm—as key regulators of T cell metabolism. While MECR is not required for naive T cell maintenance, its loss in activated T cells impairs proliferation, survival, and differentiation. MECR deficiency disrupts mitochondrial respiration, alters TCA cycle activity, and increases ferroptosis sensitivity, ultimately reducing T cell fitness and inflammatory capacity.
Sources: en.wikipedia.org
He played only seven games in 1997, and, although he was named captain in 1998 (a position he held until the end of 2005), he was restricted to thirteen games that year due to injury-related issues. An even worse year followed in 1999, with stress fractures in his foot keeping him to only two games.
=== Lymphatic absorption mechanism === Elucidation of intestinal lymphatic absorption mechanism from solid lipid nanoparticles using Caco-2 cell line as in vitro model was developed. Several researchers have shown the enhancement of oral bioavailibility of poorly water-soluble drugs when encapsulated in solid lipid nanoparticle. This enhanced bioavailibility is achieved via lymphatic delivery. To elucidate the absorption mechanism, from solid lipid nanoparticle, human excised Caco-2 cell monolayer could be alternative tissue for development of an in-vitro model to be used as a screening tool before animal studies are undertaken. The results obtained in this model suggested that the main absorption mechanism of carvedilol loaded solid lipid nanoparticle could be endocytosis and, more specifically, clathrin-mediated endocytosis.
In 2005, the Siuzdak lab was engaged in identifying metabolites associated with sepsis and in an effort to address the issue of statistically identifying the most relevant dysregulated metabolites across hundreds of LC/MS datasets, the first algorithm was developed to allow for the nonlinear alignment of mass spectrometry metabolomics data. Called XCMS, it has since (2012) been developed as an online tool and as of 2019 (with METLIN) has over 30,000 registered users. On 23 January 2007, the Human Metabolome Project, led by David S. Wishart, completed the first draft of the human metabolome, consisting of a database of approximately 2,500 metabolites, 1,200 drugs and 3,500 food components. Similar projects have been underway in several plant species, most notably Medicago truncatula and Arabidopsis thaliana for several years. As late as mid-2010, metabolomics was still considered an "emerging field". Further, it was noted that further progress in the field depended in large part, through addressing otherwise "irresolvable technical challenges", by technical evolution of mass spectrometry instrumentation. In 2015, real-time metabolome profiling was demonstrated for the first time.
Pearson AM and Dutson TR (1999) HACCP in Meat, Poultry and Fish Processing, Volume 10 of Advances in meat research, Springer. ISBN 978-0-8342-1327-2. Shahidi F, Jones Y and Kitts DD (1997) Seafood safety, processing, and biotechnology, Technomic, ISBN 978-1-56676-573-2. Stellman JM (ed.) (1998) Chemical, industries and occupations Volume 3 of Encyclopaedia of Occupational Health and Safety, International Labour Organization. ISBN 978-92-2-109816-4. Stewart H (1982) Indian Fishing: Early Methods on the Northwest Coast University of Washington Press. ISBN 978-0-88894-332-3. Stewart K M (1989) Fishing Sites of North and East Africa in the Late Pleistocene and Holocene. Volume 34 of Cambridge monographs in African archaeology. Stewart KM (1994) "Early hominid utilisation of fish resources and implications for seasonality and behaviour"[link removed] Journal of Human Evolution, 27: 229–245. United Nations Development Fund for Women (1993) Fish processing Food Technology Source Book Series (UNIFEM) Series, ISBN 978-1-85339-137-8.
=== Correcting for GPS signal errors === In the 1990s, NASA scientists at JPL developed software capable of correcting for GPS signal errors, enabling accuracy within inches; it is called Real-Time GIPSY (RTG). John Deere licensed the software and used it to develop self-driving farm equipment. As of 2016, as nearly 70% of North American farmland is cultivated by self-driving tractors, which rely on RTG that was developed at NASA. Another user of RTG is Comtech Telecommunications, which is a major provider of location-based services. This technology is used in cell phones so that 9-1-1 emergency callers can be located.
Sources: en.wikipedia.org
Albania (Entry & Exit stamp may be issued upon request) Australia (Exit stamp issued upon explicit request) China (Exit stamp issued upon request when using e-Gate) Costa Rica (only at Costa Rican airports; different entry and exit stamps are made at the border crossing with Panama) El Salvador Fiji Hong Kong (no entry or exit stamps are issued; instead, landing slips are issued upon arrival only) Iran Israel (no entry or exit stamps are issued at Ben Gurion Airport, instead landing slips are issued upon arrival and departure) Japan (Exit stamp issued upon request & when not using e-Gate since July 2019) Macau (no entry or exit stamps are issued; instead, landing slips are issued upon arrival only) New Zealand South Korea (since 1 November 2016) Panama (only at Panamanian airports; stamps are made at the border crossing with Costa Rica) Republic of China (exit stamp issued upon request & when not using e-Gate) Singapore (no exit stamps since 22 April 2019) Saint Kitts and Nevis Schengen Area countries (when the Entry/Exit System becomes operational, it is anticipated that the passports of third-country nationals will not be stamped when they enter and leave the Schengen Area)
Tyrosine–tRNA ligase, cytoplasmic, also called Tyrosyl-tRNA synthetase 1, is an enzyme that in humans is encoded by the YARS1 gene (previously YARS). Like the mitochondrial variety, YARS2, this enzyme functions as a Tyrosine–tRNA ligase, meaning it functions to attach the amino acid tyrosine to its corresponding transfer RNA (tRNATyr) as part of RNA-to-protein translation.
In fact, a swab-APPI-MS system designed for explosives and narcotics detection for security applications performs very well for all types of ambient analysis using a sampling wand and swab (right figure). A particular demonstration (unpublished) showed excellent sensitivity and specificity for detection of pesticide compounds on a variety of fruits and vegetables showing detection limits for 37 priority pesticides ranging from 0.02 to 3.0 ng well below safe limits.
== The cladistic turn (1970s–1990s) == By the late 20th century lichen systematics adopted the quantitative, computer-aided methods gaining ground across biology. Numerical taxonomy (phenetics) and cladistics entered lichenology, paralleling their uptake in plant and animal studies. Researchers replaced qualitative judgement with data matrices that coded morphological, chemical, and anatomical characters, then applied algorithms to infer relationships. Phenetic studies of the 1970s grouped lichens with clustering routines; in the 1980s Willi Hennig's cladistics shifted focus to shared-derived characters (synapomorphies) for reconstructing evolutionary trees. The shift required clear definitions of characters and explicit decisions about which traits were primitive or derived. Analyses became repeatable and easy to update as new characters or taxa were added. Robert Lücking (2020) called this methodological turn a milestone on par with the invention of the microscope for taxonomy. The new methods added rigour and standardization, aligning lichen systematics with broader evolutionary biology. Manuals on numerical and cladistic techniques were widely adopted, and phylogenetic workshops became regular features of lichen conferences. Cladistic rigour prompted a reassessment of single-trait classifications. Earlier systems frequently anchored families or genera on a single trait—spore septation, a particular metabolite, and so on. Cladistic analyses showed that such one-character groupings often masked true relationships.
Sources: en.wikipedia.org
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide intermediate in NAD+ biosynthesis.
NMN is a direct precursor in the salvage pathway that produces NAD+. Enzymes called NMN adenylyltransferases convert NMN into NAD+, a coenzyme involved in redox reactions and signaling.
No. Nicotinamide riboside is a related compound that lacks the phosphate group present in NMN. Both can influence NAD+ pathways, but their structures, transport, and metabolism differ.
Solid NMN is often stored frozen, desiccated, and protected from light. Aqueous solutions are less stable and generally require colder storage or fresh preparation.